Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iduna Fichtner

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|November 19, 2014
A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment optionKonrad Klinghammer, Jan-Dirk Raguse, Thomas Plath, et al.
International Journal of Cancer|July 13, 2002
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatmentStefanie Naundorf, Susanne Preithner, Petra Mayer, et al.
Journal of Medicinal Chemistry|January 22, 2005
Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agentsJane M Berry, Tracey D Bradshaw, Iduna Fichtner, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2014
Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinibHelen J Hülsmann, Jana Rolff, Christian Bender, et al.
Neoplasia (New York, N.Y.)|November 19, 2020
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicineMaria Rivera, Iduna Fichtner, Annika Wulf-Goldenberg, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2005
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3Bernd Schlereth, Petra Kleindienst, Iduna Fichtner, et al.
Investigational New Drugs|January 13, 2010
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor modelsAndries M Bergman, Auke D Adema, Jan Balzarini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivoShabnam Shalapour, Andrea Zelmer, Madlen Pfau, et al.
Cancer Biology & Therapy|March 8, 2011
Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancerWen Lee Tan, Bhaskar Bhattacharya, Marie Loh, et al.
Nucleic Acids Research|December 4, 2016
QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experimentsMatthias Lienhard, Sabrina Grasse, Jana Rolff, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|November 19, 2014
A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment optionKonrad Klinghammer, Jan-Dirk Raguse, Thomas Plath, et al.
International Journal of Cancer|July 13, 2002
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatmentStefanie Naundorf, Susanne Preithner, Petra Mayer, et al.
Journal of Medicinal Chemistry|January 22, 2005
Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agentsJane M Berry, Tracey D Bradshaw, Iduna Fichtner, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2014
Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinibHelen J Hülsmann, Jana Rolff, Christian Bender, et al.
Neoplasia (New York, N.Y.)|November 19, 2020
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicineMaria Rivera, Iduna Fichtner, Annika Wulf-Goldenberg, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2005
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3Bernd Schlereth, Petra Kleindienst, Iduna Fichtner, et al.
Investigational New Drugs|January 13, 2010
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor modelsAndries M Bergman, Auke D Adema, Jan Balzarini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivoShabnam Shalapour, Andrea Zelmer, Madlen Pfau, et al.
Cancer Biology & Therapy|March 8, 2011
Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancerWen Lee Tan, Bhaskar Bhattacharya, Marie Loh, et al.
Nucleic Acids Research|December 4, 2016
QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experimentsMatthias Lienhard, Sabrina Grasse, Jana Rolff, et al.
Pageof 12